This review aims to provide a comprehensive overview of the latest progress in understanding the relationship between PDE4 and cancer, examining its molecular mechanisms in tumorigenesis, drug resistance, and immunotherapy, summarizing the status and challenges of PDE4 inhibitors in tumor treatment, and prospecting the future research directions. Here, PDE4A is linked to neoplasm.